A neuroendocrine tumour is a rare tumour that can develop in many different organs of the body. It affects the cells that release hormones into the bloodstream (neuroendocrine cells).
Get advice about coronavirus and cancer:
The symptoms of a neuroendocrine tumour depend on where in the body it is and what hormones it produces.
A tumour in the lung (pulmonary neuroendocrine tumour) may cause wheezing or a persistent cough.
Some tumours may lead to abnormally large amounts of hormones being released into the bloodstream. These are known as "functioning tumours" and can cause symptoms such as diarrhoea, flushing, cramps, wheezing, low blood sugar (hypoglycaemia), changes in blood pressure and heart problems.
The cause of neuroendocrine tumours is not fully understood.
However, your chance of developing a tumour is increased if you have 1 of the following inherited conditions:
Types of scans used include:
How a neuroendocrine tumour is treated will depend on your individual circumstances, such as:
Unfortunately, many people are only diagnosed after the tumour has spread to other parts of the body.
However, it may still be possible to use surgery to remove the tumour. If surgery cannot completely cure your condition, it may be used to help reduce and manage any symptoms.
Medicine called somatostatin analogues, such as octreotide or lanreotide, may be recommended. They stop your body producing too many hormones, and can reduce the severity of your symptoms and slow the condition's progression. You'll have an injection, usually once every 28 days.
It may also be possible to shrink the tumour or stop it growing using treatments that block its blood supply (embolisation), or using chemotherapy, radiotherapy or radiofrequency ablation (where heat is used to destroy the cells).
There are also other treatments – including everolimus, sunitinib and lutetium – that can be used to treat some neuroendocrine tumours in adults if:
Everolimus is taken as a tablet, sunitinib is taken as a capsule and lutetium is given into a vein.
For more information, see: